RedHill Biopharma (RDHL) Return on Equity [ROE] (2013 - 2022)
RedHill Biopharma's Return on Equity [ROE] came in at -45106.22% for the quarter ended Mar 31, 2022, down 44861.46 percentage points from -244.76% a year earlier and down 44149.08 percentage points from the prior quarter.
Powered by 
Analysis
RedHill Biopharma (RDHL) Return on Equity [ROE] (2013 - 2022) Analysis & Trends
For the year ended Dec 31, 2021, RedHill Biopharma's Return on Equity [ROE] was -859.70%, down 653.46 percentage points from the prior year.
- Return on Equity [ROE] carries a five-year change of -907.55 percentage points (years ended Dec 2016 to Dec 2021).
- Going back by year, Return on Equity [ROE] was -206.25% in the year ended Dec 31, 2020 (-130.15 pp), -76.09% in the year ended Dec 31, 2019 (+4.57 pp), -80.66% in the year ended Dec 31, 2018 (+3.86 pp) and -84.52% in the year ended Dec 31, 2017 (-132.37 pp).
- The figure for the quarter ended Mar 31, 2022 represents the lowest quarterly Return on Equity [ROE] in data going back to the quarter ended Sep 30, 2013.
- Year-over-year, Return on Equity [ROE] has declined for 11 consecutive quarters, with an average year-over-year change of -5790.77 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in the quarter ended Jun 30, 2019 (a gain of 46.57 percentage points), and the weakest in the quarter ended Mar 31, 2022 (a drop of 44861.46 percentage points).
- Business Quant data shows RDHL's Return on Equity [ROE] at -957.15% (quarter ended Dec 31, 2021), -475.09% (quarter ended Sep 30, 2021) and -229.85% (quarter ended Jun 30, 2021) in the three quarters before the quarter ended Mar 31, 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | RedHill Biopharma | 7.09 Mn | 7.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | -45,106.22% |
| Dec 31, 2021 | -957.15% |
| Sep 30, 2021 | -475.09% |
| Jun 30, 2021 | -229.85% |
| Mar 31, 2021 | -244.76% |
| Dec 31, 2020 | -357.54% |
| Sep 30, 2020 | -200.63% |
| Jun 30, 2020 | -139.92% |
| Mar 31, 2020 | -95.69% |
| Dec 31, 2019 | -102.12% |
| Sep 30, 2019 | -139.88% |
| Jun 30, 2019 | -104.49% |
| Mar 31, 2019 | -83.29% |
| Dec 31, 2018 | -85.29% |
| Sep 30, 2018 | -126.39% |
| Jun 30, 2018 | -151.06% |
| Mar 31, 2018 | -115.25% |
| Dec 31, 2017 | -115.26% |
| Sep 30, 2017 | -64.72% |
| Jun 30, 2017 | -37.52% |
API Access
RedHill Biopharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();